Science and Technology Committee, Scrutiny, Clinical trials,
Clinical trials
16 April 2013
The Science and Technology Committee evidence session in its inquiry into ‘Clinical trials’ on Wednesday 17 April at 9.00 a.m. has, as a result of the House agreeing to Sittings of the House (Wednesday 17 April) (Motion) on Tuesday 16 April, been rescheduled to:
Monday 22 April 2013
Committee Room 8 (to be confirmed)
At 5.15 pm
- Catherine Elliott, Director, Clinical Research Interests, Medical Research Council
- Sharmila Nebhrajani, Chief Executive, Association of Medical Research Charities
- Professor Peter Johnson, Chief Clinician, Cancer Research UK
- Representative from the Wellcome Trust;
At 6.15 pm
- Dr Bina Rawal, Director of Research, Medical and Innovation, Association of the British Pharmaceutical Industry
- Dr James Shannon, Chief Medical Officer, GlaxoSmithKline
- Mr William M. Burns, Member of the Board of Directors, Roche
Further evidence sessions will be announced in due course.
Image: iStockphoto